News EPFL

Toward more efficient hydrogen production

Published:12.06.25 — Scientists at EPFL have unraveled the details of the first crucial step in the oxygen evolution reaction, a bottleneck for clean hydrogen production, using advanced simulations and machine learning techniques.

AI making it easier to diagnose tuberculosis in sub-Saharan Africa

Published:10.06.25 — EPFL and Lausanne University Hospital (CHUV) are part of an African-EU partnership awarded €10-million by the EU’s Global Health EDCTP3 Joint Undertaking to roll-out an AI-driven application for more accessible and cost-effective tuberculosis (TB) diagnosis.

Ultra-selective aptamers give viruses a taste of their own medicine

Published:06.06.25 — Inspired by the way viruses attach to cells, EPFL scientists have developed a method for engineering ultra-selective aptamers. These synthetic molecules bind to specific targets like viral spike proteins, making them useful for biomedical diagnostics and treatments.

How bigger molecules can help quantum charge flow last longer

Published:04.06.25 — A team at EPFL and the University of Arizona has discovered that making molecules bigger and more flexible can actually extend the life of quantum charge flow, a finding that could help shape the future of quantum technologies and chemical control.

Composites are going low-carbon

Published:03.06.25 — Researchers at EPFL and its startups are exploring innovative composites that are self-repairing, self-curing and reusable, in an effort to help drive the transition to a low-carbon, circular economy.